Gyon Technologies Capital Management’s Gilead Sciences GILD Stock Holding History

Gyon Technologies Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,267	Closed	-$1.99M	–	530
2022 Q3	$1.99M	Buy	32,267 +26,675	+477%	+$1.68M	0.62%	45
2022 Q2	$346K	Sell	5,592 -2,155	-28%	-$133K	0.1%	233
2022 Q1	$461K	Buy	+7,747	New	+$495K	0.32%	107
2021 Q2	–	Sell	-16,252	Closed	-$1.05M	–	411
2021 Q1	$1.05M	Sell	16,252 -63,023	-79%	-$4.06M	0.46%	43
2020 Q4	$4.62M	Buy	79,275 +64,285	+429%	+$3.88M	1.59%	5
2020 Q3	$947K	Buy	14,990 +4,594	+44%	+$319K	0.74%	25
2020 Q2	$800K	Buy	+10,396	New	+$797K	1.94%	14

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gyon Technologies Capital Management's GILD Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 32,267 shares — an estimated $1.99M sold.

Gyon Technologies Capital Management first reported a position in GILD in Q2 2020 and held it in 7 quarters. The position peaked at $4.62M in Q4 2020. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Gyon Technologies Capital Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 32,267 Gilead Sciences shares in Q4 2022, an estimated $1.99M.
Gyon Technologies Capital Management first reported a position in Gilead Sciences in Q2 2020 and held it in 7 quarters.
Gyon Technologies Capital Management's Gilead Sciences position peaked at $4.62M in Q4 2020.
1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.